Analyst Color - Spark Newswire

2 minute read

Nio Will Dominate China’s EV Market: Navellier

Today, 6:34 AM

Tesla, Inc (NASDAQ: TSLA) cancelled the Model S Plaid Plus, which was supposed to be equipped with Tesla’s innovative lower weight 4680 battery cells, which would provide longer range and more power, Louis Navellier, market strategist and founder of Navellier & Associates, said in a new

NIO

1 minute read

Why This Anavex Life Sciences Analyst Is Lifting Their Price Target

By Nikhil Dayal

Today, 6:34 AM

A Cantor Fitzgerald analyst is incrementally bullish on shares of Anavex Life Sciences, Corp (NASDAQ: AVXL) after the release of Phase 2 data for the company's lead candidate.

AVXL

2 minute read

Why This dLocal Analyst Is Bullish On Fintech Stock

By Nikhil Dayal

Today, 6:34 AM

The driver of Uruguayan fintech company DLocal Ltd's (NASDAQ: DLO) growth is its ability simplify payments by addressing pain points in emerging markets, according to. BofA Securities analyst.

DLO

2 minute read

July 4 Weekend Room Rates In Las Vegas Now 50% Above Pre-Pandemic Levels

By Wayne Duggan

Today, 6:34 AM

It’s been a long road back for Las Vegas casinos since the pandemic hit last year, but one metric suggests next weekend could be a big weekend for Vegas.

CZR

2 minute read

Why This MindMed Analyst Is Bullish: ‘One Of The Most Diverse Pipelines In Psychedelics’

By Wayne Duggan

Today, 6:34 AM

Mind Medicine (MindMed) Inc (NASDAQ: MNMD) shares traded higher by 3.3% on Monday after one analyst initiated bullish coverage of the psychedelics stock. The Analyst: Maxim analyst Jason McCarthy initiated coverage of MindMed with a Buy rating and $6 price target.

MNMD

2 minute read

Why Tesla’s China Recall Is A ‘Black Eye’ Moment For The EV Maker In The Key Region

By Shanthi Rexaline

Today, 6:34 AM

Tesla Inc (NASDAQ: TSLA) is facing a setback in China, a region that is key to its growth plans going forward. The Tesla Analyst: Wedbush analyst Daniel Ives has an Overweight rating and a $1,000 price target for Tesla shares.

TSLA

2 minute read

JNJ’s $260M Settlement Could Serve As Global Opioid Deal Template: Analyst

By Wayne Duggan

Today, 6:34 AM

Over the weekend, Johnson & Johnson (NYSE: JNJ) reached a major opioid litigation settlement that could have broader implications for the biopharmaceutical industry.

ABC

1 minute read

Medicenna Therapeutics Shares Spike To Session High, Now Up 6%, As Traders Circulate Buy Rating, $12 Price Target From Zacks

By Benzinga Newsdesk

Today, 6:34 AM

https://s27.q4cdn.com/906368049/files/News/2021/Zacks_SCR_Research_06282021_MDNA_Bautz.pdf

MDNA

2 minute read

Why Intellia Therapeutics Stock Is Soaring Today

By Adam Eckert

Today, 6:34 AM

Intellia Therapeutics Inc (NASDAQ: NTLA) is trading significantly higher Monday morning after the company announced positive clinical data for its CRISPR therapy.

NTLA

2 minute read

5 FedEx Analysts Break Down Q4 Earnings: ‘We Continue To See Upside Potential’

By Wayne Duggan

Today, 6:34 AM

FedEx Corporation (NYSE: FDX) traded lower by 4% on Friday after the company delivered lackluster fiscal fourth-quarter numbers on Thursday afternoon.

FDX